Skip to main content
Premium Trial:

Request an Annual Quote

ChondroGene Completes GeneNews Acquisition

NEW YORK, Dec. 1 (GenomeWeb News) - ChondroGene said today that it has completed its acquisition of GeneNews.

 

Under the deal, ChondroGene acquires all outstanding shares of GeneNews in exchange for 4 million shares of its own stock at a price of $0.50 per share.

 

According to Toronto-based ChondroGene, GeneNews' principal asset is undisclosed intellectual property related to pharmacogenomics and personalized medicine. ChondroGene, which was co-founded by GeneNews founder Choong-Chin Liew, previously held licensing rights to the technology in the fields of osteoarthritis, rheumatoid arthritis, and traumatic joint injury.

 

 

The Scan

Boosters Chasing Variants

The New York Times reports that an FDA advisory panel is to weigh updated booster vaccines for COVID-19.

Not Yet

The World Health Organization says monkeypox is not yet a global emergency, the Washington Post reports.

More Proposed for Federal Research

Science reports that US House of Representatives panels are seeking to increase federal research funding.

PLOS Papers on Breast Cancer Metastasis, Left-Sided Cardiac Defects, SARS-CoV-2 Monitoring

In PLOS this week: link between breast cancer metastasis and CLIC4, sequencing analysis of left-sided cardiac defects, and more.